據報小米汽車已實現小批量試生產 新車或明年2月上市
據《每日經濟新聞》報道,日前到小米(01810.HK)旗下北京經開區小米汽車工廠實探其生產基地發現,生產廠房已初見規模,辦公大樓帶有小米LOGO,大貨車和黃色工程車不時穿梭其間。
報道引述零部件供應商張海透露,小米汽車一期工廠內四大製造工藝(衝壓、焊接、塗裝、總裝)車間均已建好,並已開始小批量試生產。
報道又引述知情人士表示,小米汽車將在下月開始批量生產,明年2月上市開賣。
按照小米董事長雷軍的規劃,小米汽車的首款車型計劃第一年銷售10萬輛,此後三年累計交付90萬輛,意味著於2025年至2027年,小米汽車每年所需產能至少為30萬輛。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.